Greenlight Biosciences

OverviewSuggest Edit

GreenLight Biosciences is a biotechnology company focused on the sustainable production of chemicals and fuels using its Unconstrained Metabolism ® technology platform. The Company's patented Cell-free Bioprocessing technology offers a sustainable, efficient, clean, and economical way to produce the chemicals commonly used in food, pharmaceuticals, agriculture, and non-petroleum based fuels.

Cell-free Bioprocessing is an unprecedented flexible biomanufacturing platform that preserves the cell's inherent manufacturing capabilities while eliminating the cumbersome need to keep the host organism alive.

TypePrivate
Founded2008
HQMedford, MA, US
Websitegreenlightbiosciences.com
Employee Ratings4.2

Recent NewsAll News

Latest Updates

Employees (est.) (Jun 2021)216(+10%)
Cybersecurity ratingAMore

Key People/Management at Greenlight Biosciences

Carole Cobb

Carole Cobb

Chief Operating Officer
Susan Keefe

Susan Keefe

Chief Financial Officer
Charu Manocha

Charu Manocha

Chief People Officer
Andrey J. Zarur

Andrey J. Zarur

Co-Founder, President, & CEO, Director
Marta Ortega-Valle

Marta Ortega-Valle

Co-Founder & Chief Business Officer, Human Health
Charles L. Cooney

Charles L. Cooney

Director
Show more

Greenlight Biosciences Office Locations

Greenlight Biosciences has an office in Medford
Medford, MA, US (HQ)
196 Boston Ave
Show all (1)

Greenlight Biosciences Financials and Metrics

Summary Metrics

Founding Date

2008

Greenlight Biosciences total Funding

$215 m

Greenlight Biosciences latest funding size

$102 m

Time since last funding

a year ago

Greenlight Biosciences investors

Greenlight Biosciences's latest funding round in June 2020 was reported to be $102 m. In total, Greenlight Biosciences has raised $215 m
Show all financial metrics

Greenlight Biosciences Cybersecurity Score

Cybersecurity ratingPremium dataset

A

94/100

SecurityScorecard logo

Greenlight Biosciences Online and Social Media Presence

Embed Graph

Greenlight Biosciences News and Updates

GreenLight Biosciences Publishes Blueprint to Vaccinate the World

BOSTON, March 26, 2021 /PRNewswire/ -- GreenLight Biosciences today published its Blueprint to Vaccinate the World. This plan lays out how the world can quickly end the Covid pandemic by investing in a global network of seven vaccine manufacturing plants. This plan lays out how national...

GreenLight Biosciences Welcomes Mark Singleton As Lead For Plant Health Innovation

BOSTON, March 3, 2021 /PRNewswire/ -- GreenLight Biosciences, Inc., a biotechnology company focused on RNA research, design and manufacturing for human, animal and plant health, today announced the appointment of Mark Singleton as the company's Senior Vice President of Technology and...

Greenlight Biosciences Welcomes Thomas Crampton as Senior Vice President for Corporate Affairs

BOSTON, Jan. 27, 2021 /PRNewswire/ -- GreenLight Biosciences, Inc., a biotechnology company focused on RNA research, design and manufacturing for human, animal and plant health, today announced the appointment of Thomas Crampton as the company's Senior Vice President for Corporate Affairs....

GreenLight Biosciences welcomes Charu Manocha as Chief People Officer

BOSTON, Oct. 1, 2020 /PRNewswire/ -- GreenLight Biosciences, Inc., an integrated life sciences company developing RNA-based products for plant health, human health and animal health, today announced Charu Manocha as the company's new Chief People Officer. "Charu brings a track record of...

Greenlight Biosciences Blogs

The Economist: RNA for Bees and Crops

The post The Economist: RNA for Bees and Crops appeared first on GreenLight Biosciences.

The Economist: RNA for pesticides

The post The Economist: RNA for pesticides appeared first on GreenLight Biosciences.

Protecting honeybees from the Varroa destructor mite

The post Protecting honeybees from the Varroa destructor mite appeared first on GreenLight Biosciences.

GreenLight acquires Bayer’s topical RNA Intellectual Property portfolio

The post GreenLight acquires Bayer’s topical RNA Intellectual Property portfolio appeared first on GreenLight Biosciences.

The National: Africa needs to be self-reliant in vaccine production

The post The National: Africa needs to be self-reliant in vaccine production appeared first on GreenLight Biosciences.

Amin Khan welcomed as Chief Scientific Officer, Human Health

The post Amin Khan welcomed as Chief Scientific Officer, Human Health appeared first on GreenLight Biosciences.
Show more

Greenlight Biosciences Frequently Asked Questions

  • When was Greenlight Biosciences founded?

    Greenlight Biosciences was founded in 2008.

  • Who are Greenlight Biosciences key executives?

    Greenlight Biosciences's key executives are Carole Cobb, Susan Keefe and Charu Manocha.

  • How many employees does Greenlight Biosciences have?

    Greenlight Biosciences has 216 employees.

  • Who are Greenlight Biosciences competitors?

    Competitors of Greenlight Biosciences include Concept Life Sciences, ISOLAB Laborgerate and Rocky Mountain Labs.

  • Where is Greenlight Biosciences headquarters?

    Greenlight Biosciences headquarters is located at 196 Boston Ave, Medford.

  • Where are Greenlight Biosciences offices?

    Greenlight Biosciences has an office in Medford.

  • How many offices does Greenlight Biosciences have?

    Greenlight Biosciences has 1 office.